AIMC Topic: Device Approval

Clear Filters Showing 11 to 20 of 22 articles

Robotic surgery: new robots and finally some real competition!

World journal of urology
PURPOSE: For the last 20 years, the predominant robot used in laparoscopic surgery has been Da Vinci by Intuitive Surgical. This monopoly situation has led to rising costs and relatively slow innovation. This article aims to discuss the two new robot...

Role of AI in Clinical Decision-Making: An Analysis of FDA Medical Device Approvals.

Studies in health technology and informatics
The U.S. Food and Drug Administration (FDA) plays an important role in ensuring safety and effectiveness of AI/ML-enabled devices through its regulatory processes. In recent years, there has been an increase in the number of these devices cleared by ...

Navigating FDA Regulations for the Development of Artificial Intelligence Technologies in Plastic Surgery.

Aesthetic surgery journal
Artificial intelligence (AI) technologies are rapidly transforming the field of plastic surgery, offering new opportunities for improving patient outcomes through enhanced diagnostic capabilities, personalized treatment planning, and outcome predicti...

Evaluating the Impact of the EU AI Act on Medical Device Regulation.

Studies in health technology and informatics
Artificial Intelligence (AI) is increasingly incorporated into medical devices, revolutionizing diagnostics, treatment planning, and patient monitoring. To ensure AI's safe and ethical use, the European Commission published the AI Act in 2024, which ...

FDA Perspective on the Regulation of Artificial Intelligence in Health Care and Biomedicine.

JAMA
IMPORTANCE: Advances in artificial intelligence (AI) must be matched by efforts to better understand and evaluate how AI performs across health care and biomedicine as well as develop appropriate regulatory frameworks. This Special Communication revi...

Conflicting information from the Food and Drug Administration: Missed opportunity to lead standards for safe and effective medical artificial intelligence solutions.

Journal of the American Medical Informatics Association : JAMIA
The Food & Drug Administration (FDA) is considering the permanent exemption of premarket notification requirements for several Class I and II medical device products, including several artificial Intelligence (AI)-driven devices. The exemption is bas...